Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A legitimate COA includes the testing date, lot number matching your product, purity percentage (typically 98%+ for research-grade peptides), and specific test methods used
Mandatory Regulatory & Compliance Disclaimer
MT-II is not approved by the FDA, TGA, MHRA, or any regulatory body
For more information, check out our blog that covers the difference between ipamorelin and hexarelin
Luvo Health Longevity Program Consumer Research 2026: Is Clinician-Guided NAD+ and Sermorelin Right for You
Key safety monitoring parameters include: Baseline and periodic assessment of nutritional status (complete blood count, comprehensive metabolic panel, vitamin levels, albumin) Renal function monitoring, particularly during dose escalation, due to risk of acute kidney injury from dehydration Evaluation for gastrointestinal symptoms and differentiation from surgical complications Monitoring for gallbladder disease, which may be increased with weight loss and semaglutide use Assessment of medication adherence and injection technique Eye examination in patients with diabetes due to potential risk of diabetic retinopathy progression with rapid glycemic improvement Regular follow-up with both bariatric surgery and endocrinology or obesity medicine teams when possible Patients should be counseled to report severe or persistent nausea, vomiting, abdominal pain, or inability to maintain adequate hydration or nutrition, as these may warrant dose adjustment, temporary discontinuation, or further evaluation for surgical complications
US$ 29.22
US$ 22.22
US$ 24.24
US$ 22.42
US$ 29.17
